ProQR Therapeutics N.V. Operating Expenses 2011-2026 | PRQR

Annual Operating Expenses ProQR Therapeutics N.V.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
59.8 M	50 M	41.4 M	69.5 M	59.6 M	51.8 M	59.4 M	42.1 M	42 M	39.8 M	27 M	16.5 M	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
69.5 M	16.5 M	46.6 M

Quarterly Operating Expenses ProQR Therapeutics N.V.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	18.3 M	17.8 M	15.7 M	13.9 M	12.2 M	11.9 M	11.1 M	12 M	16.7 M	17.8 M	14 M	12.4 M	15.2 M	-	8.88 M	8.64 M	-	-	-	10.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
18.3 M	8.64 M	13.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	90.2 M	$ 8.64	8.07 %	$ 85.4 M	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.66	-1.48 %	$ 8.81 B	Australia
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	216 M	$ 21.36	4.86 %	$ 998 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	173 M	$ 1.47	5.0 %	$ 378 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.92	-	$ 4.81 M	Israel
Aquestive Therapeutics AQST	85.5 M	$ 4.19	2.7 %	$ 448 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 24.12	-0.37 %	$ 3.07 B	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 32.59	1.09 %	$ 2.16 B	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.47	-1.34 %	$ 391 M	Britain
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	177 M	-	-	$ 1.41 B	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Akari Therapeutics, Plc AKTX	17.3 M	$ 4.25	8.35 %	$ 286 B	Britain
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Esperion Therapeutics ESPR	343 M	$ 2.22	2.3 %	$ 461 M	USA
Evogene Ltd. EVGN	13.8 M	$ 0.82	1.13 %	$ 27.9 M	Israel
Baudax Bio BXRX	54.6 M	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	172 M	$ 3.2	2.24 %	$ 322 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA